Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
pembrolizumab severe side effects | 1.29 | 1 | 9792 | 45 | 33 |
pembrolizumab | 1.66 | 0.6 | 5114 | 48 | 13 |
severe | 1.42 | 0.1 | 257 | 40 | 6 |
side | 0.29 | 0.5 | 7022 | 46 | 4 |
effects | 0.62 | 0.7 | 4087 | 97 | 7 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
pembrolizumab severe side effects | 1.42 | 0.6 | 8134 | 62 |
pembrolizumab side effects chemocare | 0.78 | 0.7 | 3135 | 39 |
pembrolizumab side effects heart | 0.07 | 0.5 | 7207 | 64 |
pembrolizumab side effects lung | 0.77 | 1 | 2916 | 13 |
pembrolizumab side effects uptodate | 1.67 | 0.8 | 3579 | 64 |
pembrolizumab ocular side effects | 1.95 | 0.6 | 3625 | 64 |
pembrolizumab side effects kidney | 0.26 | 0.6 | 3683 | 91 |
pembrolizumab immune related adverse events | 1.18 | 0.1 | 315 | 57 |
nivolumab and pembrolizumab side effects | 1.08 | 0.4 | 1972 | 43 |
pembrolizumab keytruda side effects | 0.11 | 0.3 | 8698 | 71 |
pembrolizumab patient information leaflet | 1.19 | 0.4 | 6738 | 68 |
pembrolizumab shortness of breath | 1.03 | 0.6 | 6193 | 72 |
pembrolizumab and cardiac toxicity | 1.5 | 0.1 | 1711 | 41 |
is pembrolizumab a hazardous drug | 1.8 | 0.9 | 9780 | 91 |
pembrolizumab fiche info patient | 1.76 | 1 | 8622 | 24 |